Literature DB >> 11934781

From guidance to practice: Why NICE is not enough.

Thomas H S Dent1, Mike Sadler.   

Abstract

Mesh:

Year:  2002        PMID: 11934781      PMCID: PMC1122771          DOI: 10.1136/bmj.324.7341.842

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Why not [symbol: see text]zanamivir?

Authors: 
Journal:  Drug Ther Bull       Date:  2001-02

2.  An integrated national pharmaceutical policy for the United Kingdom?

Authors:  T Walley; A Earl-Slater; A Haycox; A Bagust
Journal:  BMJ       Date:  2000-12-16

3.  The failings of NICE.

Authors:  R Smith
Journal:  BMJ       Date:  2000-12-02

4.  Effectiveness, efficiency, and NICE.

Authors:  M Sculpher; M Drummond; B O'Brien
Journal:  BMJ       Date:  2001-04-21

5.  Too soon to market.

Authors:  T H Dent; S Hawke
Journal:  BMJ       Date:  1997-11-15
  5 in total
  4 in total

Review 1.  Evidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groups.

Authors:  W A Rogers
Journal:  J Med Ethics       Date:  2004-04       Impact factor: 2.903

Review 2.  Evidence based medicine guidelines: a solution to rationing or politics disguised as science?

Authors:  S I Saarni; H A Gylling
Journal:  J Med Ethics       Date:  2004-04       Impact factor: 2.903

3.  Healthcare Professionals' Perceptions of Type 2 Diabetes Mellitus Care in the Mediterranean Region.

Authors:  Charles Savona-Ventura; Josanne Vassallo
Journal:  Diabetes Ther       Date:  2019-07-31       Impact factor: 2.945

4.  Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study.

Authors:  O M McNally; E Delaney; R D Petty; M E Cruickshank; A W Hutcheon; D E Parkin
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.